While not reaching statistical significance, these trends were largely driven by the PAD cohort, in whom the hs‐CRP level decreased from 3.7±0.93 to 3.0±0.6 mg/L (P=0.325) and the IL‐6 level decreased from 5.1±1.4 to 3.8±0.8 pg/mL (P=0.147). Here, CRP is linked to peripheral arterial disease.